Adherence
Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring systems improve glycemic control and reduce hypoglycemia risk in patients with Type 2 Diabetes, particularly those on insulin therapy.
If you have Type 2 Diabetes and are on insulin, ask your doctor about Continuous Glucose Monitoring (CGM) or Flash Glucose Monitoring systems. These devices provide real-time data on your blood sugar levels and trends, helping you and your doctor adjust your insulin doses more precisely and safely, reducing the risk of dangerous lows.
Recent technological developments offer useful ways to simplify glucose monitoring and increase the precision and safety of insulin therapy... Flash glucose monitoring is more expensive than SMBG 8.3 times per day in the UK, which is more frequently than the typical testing frequency seen in T2D patients... CGMs... can be used to circumvent the drawbacks of flash glucose monitoring and provide notifications without the need to physically scan a sensor.
Why this rating
Based on clinical trials and observational studies of CGM and Flash monitoring systems.
Source
Technological and Therapeutic Approaches to Type 2 Diabetes Management
Rekha Krishnan et al. · International Journal of Health Sciences and Research · 2023
DOI 10.52403/ijhsr.20230320
More from this paper
- GLP-1 receptor agonists (GLP-1RAs) significantly reduce major adverse cardiovascular events (MACE) and all-cause mortality in patients with type 2 diabetes, with specific agents like liraglutide and semaglutide demonstrating superior efficacy.Strong
- SGLT-2 inhibitors (SGLT-2is) reduce major adverse cardiovascular events and renal outcomes in patients with Type 2 Diabetes, with specific agents like empagliflozin and canagliflozin showing significant benefits.Strong
- Tirzepatide, a dual GIP and GLP-1 receptor agonist, demonstrates superior glycemic control and weight loss compared to semaglutide and insulin degludec in patients with Type 2 Diabetes.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →